Cargando…
Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
BACKGROUND: To evaluate the functional recovery of patients with symptomatic vitreomacular traction (VMT) after Ocriplasmin treatment. METHODS: Prospective, single centre, consecutive case series. Patients were treated with a single intravitreal injection of Ocriplasmin (Jetrea, Thrombogenics Inc, U...
Autores principales: | Rossi, Settimio, Testa, Francesco, Melillo, Paolo, Orrico, Ada, Della Corte, Michele, Simonelli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949888/ https://www.ncbi.nlm.nih.gov/pubmed/27430356 http://dx.doi.org/10.1186/s12886-016-0284-3 |
Ejemplares similares
-
Ocriplasmin use in a selected case with preserved visual acuity
por: Rossi, Settimio, et al.
Publicado: (2015) -
Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016) -
Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014) -
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020) -
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)